Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole Premedication for Gastric ESD
NCT02730533Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of esomeprazole in gastric cancer (GC) (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Total bleeding rate according to grading of intraoperative bleeding during ESD procedure at 1 day. Started Mar 2016; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02730533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730533.